CHARM: the AI model that can genomically profile gliomas
AI can now genomically profile brain tumors during surgery, offering real-time guidance on how best to remove or treat the glioma.
A research initiative led by Harvard Medical School (MA, USA) has overcome the challenges of the current intraoperative diagnostic approach for brain tumors by using AI. The new system is called CHARM, which stands for Cryosection Histopathology Assessment and Review Machine; although the tool requires clinical validation and FDA approval, it has shown promise when identifying molecular markers of gliomas, the most aggressive and common form of brain cancer.
